QUALITY CHOICE EXTRA STRENGTH GAS RELIEF CHERRY - simethicone tablet, chewable 
Chain Drug Marketing Association Inc.

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

----------

QC ES Gas Relief Cherry

ACTIVE INGREDIENT(in each tablet)

Simethicone 125 mg

PURPOSE

Anti-gas

USE(S)

relieves:

WARNINGS

.

KEEP OUT OF REACH OF CHILDREN

In case of overdose, get medical help or contact a poison control center immediately.

DIRECTIONS

OTHER INFORMATION

INACTIVE INGREDIENTS

D&C red # 30 aluminum lake, dextrose, flavor, magnesium stearate, maltodextrin, microcrystalline cellulose, sorbitol, sucrose.

PRINCIPAL DISPLAY PANEL

NDC 63868-162-18

QC

Quality Choice

*Compare to the Active Ingredient in Extra Strength Gas-X®

Extra Strength

 Gas Relief

Antigas

Simethicone 125 mg


Relieves:

Pressure

Bloating

Gas Distress


Cherry Flavor 

18 chewable tablets


134chr-qc


QUALITY CHOICE EXTRA STRENGTH GAS RELIEF CHERRY 
simethicone tablet, chewable
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:63868-162
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
DIMETHICONE (UNII: 92RU3N3Y1O) (DIMETHICONE - UNII:92RU3N3Y1O) DIMETHICONE125 mg
Inactive Ingredients
Ingredient NameStrength
D&C RED NO. 30 (UNII: 2S42T2808B)  
MAGNESIUM STEARATE (UNII: 70097M6I30)  
CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  
SORBITOL (UNII: 506T60A25R)  
SUCROSE (UNII: C151H8M554)  
MALTODEXTRIN (UNII: 7CVR7L4A2D)  
DEXTROSE, UNSPECIFIED FORM (UNII: IY9XDZ35W2)  
Product Characteristics
ColorPINKScoreno score
ShapeROUNDSize14mm
FlavorCHERRYImprint Code G134
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:63868-162-182 in 1 CARTON08/15/2022
19 in 1 BLISTER PACK; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC MONOGRAPH FINALpart33208/15/2022
Labeler - Chain Drug Marketing Association Inc. (011920774)

Revised: 8/2022
Document Id: eb902b4c-1470-4313-b9de-ece16aec5496
Set id: eb902b4c-1470-4313-b9de-ece16aec5496
Version: 1
Effective Time: 20220815
 
Chain Drug Marketing Association Inc.